e-SPACE Cardio-Renal-Metabolic 2022: On-demand

Published: 11 April 2022

  • Views:

    Views Icon 20287
  • Likes:

    Heart Icon 7
  • episode_image
    1m 29s
    Part 4 | Session 1 Introduction Vijay Chopra, Marco Metra
  • episode_image
    1m 9s
    Part 6 | Session 1 Introduction Andrew JS Coats, Alice Cheng
Average (ratings)
No ratings
Your rating

Overview

e-SPACE CARDIO-RENAL-METABOLIC 2022, held on 4-6 March 2022, was the second edition of the global online conference on cardio renal metabolic diseases.

 

The organisers, under the direction of a world-renowned scientific committee, brought together leading experts in cardiology, nephrology, and diabetology to share clinical practice strategies in treating the inter-related diseases now affecting hundreds of millions people worldwide.

 

This on-demand version of the event comprises:

 

  • Presentations and discussions with leading experts
  • Evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity
  • Insight to SLGT2i, GLP-1RA and other emerging therapies
  • 'Meet the Expert' sessions

 

e-SPACE Cardio-Renal-Metabolic 2022 was supported by the following companies:

More from this programme

Part 1

Meet the Expert: IgA nephropathy: current optimal management

Part 3

Industry Session: Iron deficiency in heart failure and kidney disease: interdisciplinary crosstalk

Part 5

Meet the Experts: NAFLD/NASH as a metabolic disease: improving patients outcomes

Part 7

Meet the Experts: The meaning of Hemoglobin A1C for the nephrologist and the cardiologist

Part 12

Meet the Experts: CV, mortality & kidney outcomes with GLP-1 AR in patients with T2DM

Part 14

Meet the Experts: The HF Diabetic patient with CKD: optimizing care for a high-risk group

Part 17

Meet the Expert: HIF PHI: What do we know and don't know in 2022

Part 19

Industry Session: SGLT2 inhibition in the comorbid CKD patient

Satellite Symposium supported by an unrestricted educational grant from AstraZeneca

Part 21

Meet the Expert: SGLT2 inhibitors in heart failure: Improving outcomes across the spectrum of the disease

Part 23

Meet the Expert: The meaning of eGFR for the cardiologists and diabetologist

Part 25

Meet the Experts: Personalized care of patients with heart failure: hyperkalemia as a barrier to optimal medical therapy

Part 26

Meet the Expert: SGLT2, the statin of the 21st century

Part 28

Meet the Experts: Reducing the risk of cardiovascular events for patients with CKD and T2DM: new treatment options

Part 31

Meet the Expert: Management of worsening HF

Part 32

Session 16: Harmonising the gluco-and cardio-centric management of diabetes

Faculty Biographies

Andrew JS Coats

Andrew JS Coats

Professor of Cardiology and Scientific Director

Prof Coats is Editor-in-Chief of the Cardiac Failure Review journal. He has published over 20 patents, more than 750 full research papers and more than 120,000 career citations and has a personal H-index of 146. Andrew was elected to the Presidential Trio of the Heart Failure Association of the ESC in 2018 and will serve as its president from 2020-2022.

Prof Coats is the Immediate past-President of the Heart Failure Association and past-Professor of Cardiology at the University of Warwick, UK. He has also held posts as Head of Cardiology at Imperial College, London and Associate Medical Director and Director of Cardiology at the Royal Brompton and Harefield Hospitals, London. From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine at the University of Sydney.

He is an…

View full profile